Business Context and Reporting Period
Company: ZIMMER BIOMET HOLDINGS, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: September 18, 2020
Event: Entry into a new material definitive agreement (revolving credit facility) and termination of a prior credit agreement.
Key Financial Metrics and Debt Structure
This filing details a refinancing event rather than operational financial results. Key metrics include:
- New Facility: $1.0 billion unsecured revolving credit facility.
- Term: 364 days, maturing on September 17, 2021.
- Interest Rate: Floating rates based on LIBOR or an alternate base rate plus a margin tied to the Company's senior unsecured long-term debt credit rating.
- Outstanding Borrowings: The filing does not state the amount drawn on the new facility; it notes there were no borrowings outstanding under the terminated prior agreement.
- Revenue/Profit/Cash Flow: The filing text does not provide current revenue, profit, cash flow, or margin data.
Material Changes Versus Prior Period
The primary material change is the replacement of the Company's credit facility:
- Termination: The Credit Agreement dated April 23, 2020, was terminated on September 18, 2020.
- Replacement: A new 364-day revolving credit agreement was executed on the same date.
- Covenant Changes: The new agreement introduces specific leverage ratio covenants (Consolidated Indebtedness to Consolidated EBITDA) that were not detailed in the summary of the terminated agreement.
Guidance, Outlook, and Covenants
Management Commentary and Use of Proceeds: Borrowings under the new facility are designated for general corporate purposes.
Financial Covenants (Consolidated Leverage Ratio): The Company must maintain a ratio of no greater than:
- 5.75 to 1.00 for test periods ending between September 18, 2020, and December 31, 2020.
- 5.00 to 1.00 for the test period ending March 31, 2021.
- 4.50 to 1.00 for test periods ending after April 1, 2021.
- Note: The maximum permitted ratio may increase to 5.00 to 1.00 temporarily in connection with a qualified material acquisition on or after July 1, 2021.
Risks and Contingencies: The agreement contains customary affirmative and negative covenants, including limitations on consolidations, mergers, and sales of assets. The filing notes that lenders may provide other financial services to the Company for which they receive compensation.
Investor Verification Checklist
- Verify the Company's current senior unsecured long-term debt credit rating to determine the applicable interest margin and facility fee.
- Review the full text of the Credit Agreement (Exhibit 10.1) for detailed definitions of "Consolidated Indebtedness" and "Consolidated EBITDA."
- Confirm the Company's current leverage ratio against the 5.75:1.00 threshold applicable for the period ending December 31, 2020.
- Monitor for any qualified material acquisitions planned after July 1, 2021, which could temporarily alter leverage covenant limits.